Kronos Bio Inc

NASDAQ:KRON   3:59:53 PM EDT
17.04
+0.25 (+1.49%)
Products

Kronos Bio Announces FDA Clearance Of IND Application For KB-0742

Published: 12/07/2020 13:14 GMT
Kronos Bio Inc (KRON) - Kronos Bio Announces FDA Clearance of Investigational New Drug (ind) Application for Kb-0742, an Oral Cdk9 Inhibitor Targeting Myc-amplified Cancers.
Kronos Bio Inc - Phase 1/2 Clinical Trial to Begin in Q1 of 2021.